ABACus 3 - Awareness and Beliefs About Cancer phase 3

  • Research type

    Research Study

  • Full title

    AWARENESS AND BELIEFS ABOUT CANCER PHASE 3 (ABACUS 3): RANDOMISED CONTROLLED TRIAL OF THE HEALTH CHECK INTERVENTION TO IMPROVE CANCER SYMPTOM AWARENESS AND HELP-SEEKING AMONG PEOPLE LIVING IN SOCIOECONOMICALLY DEPRIVED COMMUNITIES

  • IRAS ID

    232998

  • Contact name

    Yvonne Moriarty

  • Contact email

    MoriartyY@cardiff.ac.uk

  • Sponsor organisation

    Cardiff University

  • Duration of Study in the UK

    2 years, 5 months, 0 days

  • Research summary

    Cancer survival rates are lower in disadvantaged communities, possibly due to low awareness of symptoms and delayed help-seeking. It is important that people increase their knowledge of cancer symptoms, so that they know when to seek medical advice, and therefore possibly detecting cancer earlier, which will improve their outlook. We have developed an interactive online health check questionnaire to be delivered in these communities by trained advisors. It asks participants 29 questions on their background, lifestyle and health. A traffic light (red, amber, green) summary page is produced based on their response, highlighting areas where action and/or advice should be taken.

    We will recruit 246 participants over 12 months who speak English, are over 40, from South West Yorkshire and South Wales and who have not taken part in ABACus 2. Participants will complete questionnaires at three time points during the trial (when recruited, two weeks and six months later). Questions will ask about their knowledge of specific and non-specific cancer symptoms, some background health information and their readiness to seek medical help and advice. All participants will receive a total of £15 in high-street voucher as a thank you for taking part. They will receive £10 after completing the baseline assessment and a further £5 after completing the 6 month follow-up assessment.

    Participants will be randomised to the treatment or control group. Those in the treatment group will complete the online health check, facilitated by an advisor. Once all follow-up data has been collected, it will be compared to test if people in the treatment group increased their cancer symptom awareness after completing the online health check. We will also investigate how the intervention was implemented and conducted (this is called a process evaluation) and evaluate the cost-effectiveness of delivering the health check. Some participants will also be asked to take part in an interview at the end of the trial to find out more about their wider experiences of cancer awareness initiatives.

  • REC name

    London - Surrey Research Ethics Committee

  • REC reference

    17/LO/1507

  • Date of REC Opinion

    12 Oct 2017

  • REC opinion

    Further Information Favourable Opinion